BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 16931575)

  • 21. Agonist and antagonists induce homodimerization and mixed ligand heterodimerization of human progesterone receptors in vivo by a mammalian two-hybrid assay.
    Leonhardt SA; Altmann M; Edwards DP
    Mol Endocrinol; 1998 Dec; 12(12):1914-30. PubMed ID: 9849965
    [TBL] [Abstract][Full Text] [Related]  

  • 22. DNA recognition by the androgen receptor: evidence for an alternative DNA-dependent dimerization, and an active role of sequences flanking the response element on transactivation.
    Haelens A; Verrijdt G; Callewaert L; Christiaens V; Schauwaers K; Peeters B; Rombauts W; Claessens F
    Biochem J; 2003 Jan; 369(Pt 1):141-51. PubMed ID: 12350223
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Molecular dynamics simulations in solvent of the glucocorticoid receptor protein in complex with a glucocorticoid response element DNA sequence.
    Harris LF; Sullivan MR; Popken-Harris PD; Hickok DF
    J Biomol Struct Dyn; 1994 Oct; 12(2):249-70. PubMed ID: 7702769
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Sequence-specific deoxyribonucleic acid (DNA) recognition by steroidogenic factor 1: a helix at the carboxy terminus of the DNA binding domain is necessary for complex stability.
    Little TH; Zhang Y; Matulis CK; Weck J; Zhang Z; Ramachandran A; Mayo KE; Radhakrishnan I
    Mol Endocrinol; 2006 Apr; 20(4):831-43. PubMed ID: 16339274
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Use of Saccharomyces cerevisiae in the identification of novel transcription factor DNA binding specificities.
    Henry KW; Carey B; Howard WR; Hoefner D; Noonan DJ
    Yeast; 2001 Mar; 18(5):445-54. PubMed ID: 11255252
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The C-terminal extension (CTE) of the nuclear hormone receptor DNA binding domain determines interactions and functional response to the HMGB-1/-2 co-regulatory proteins.
    Melvin VS; Roemer SC; Churchill ME; Edwards DP
    J Biol Chem; 2002 Jul; 277(28):25115-24. PubMed ID: 12006575
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The steroid hormone antagonist RU486. Mechanism at the cellular level and clinical applications.
    Baulieu EE
    Endocrinol Metab Clin North Am; 1991 Dec; 20(4):873-91. PubMed ID: 1778181
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Importance of the Sequence-Directed DNA Shape for Specific Binding Site Recognition by the Estrogen-Related Receptor.
    Mohideen-Abdul K; Tazibt K; Bourguet M; Hazemann I; Lebars I; Takacs M; Cianférani S; Klaholz BP; Moras D; Billas IML
    Front Endocrinol (Lausanne); 2017; 8():140. PubMed ID: 28676789
    [TBL] [Abstract][Full Text] [Related]  

  • 29. PDZ domain-mediated dimerization and homeodomain-directed specificity are required for high-affinity DNA binding by SATB1.
    Purbey PK; Singh S; Kumar PP; Mehta S; Ganesh KN; Mitra D; Galande S
    Nucleic Acids Res; 2008 Apr; 36(7):2107-22. PubMed ID: 18187506
    [TBL] [Abstract][Full Text] [Related]  

  • 30. DNA-binding mechanism of the monomeric orphan nuclear receptor NGFI-B.
    Meinke G; Sigler PB
    Nat Struct Biol; 1999 May; 6(5):471-7. PubMed ID: 10331876
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Long-range electrostatic interactions influence the orientation of Fos-Jun binding at AP-1 sites.
    Ramirez-Carrozzi VR; Kerppola TK
    J Mol Biol; 2001 Jan; 305(3):411-27. PubMed ID: 11152600
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The antagonists RU486 and ZK98299 stimulate progesterone receptor binding to deoxyribonucleic acid in vitro and in vivo, but have distinct effects on receptor conformation.
    Gass EK; Leonhardt SA; Nordeen SK; Edwards DP
    Endocrinology; 1998 Apr; 139(4):1905-19. PubMed ID: 9528977
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Self-association energetics of an intact, full-length nuclear receptor: the B-isoform of human progesterone receptor dimerizes in the micromolar range.
    Heneghan AF; Berton N; Miura MT; Bain DL
    Biochemistry; 2005 Jul; 44(27):9528-37. PubMed ID: 15996107
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Identification of a hormone-dependent phosphorylation site adjacent to the DNA-binding domain of the chicken progesterone receptor.
    Poletti A; Weigel NL
    Mol Endocrinol; 1993 Feb; 7(2):241-6. PubMed ID: 8469237
    [TBL] [Abstract][Full Text] [Related]  

  • 35. DNA-induced conformational changes are the basis for cooperative dimerization by the DNA binding domain of the retinoid X receptor.
    Holmbeck SM; Dyson HJ; Wright PE
    J Mol Biol; 1998 Dec; 284(3):533-9. PubMed ID: 9826495
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Atomic structure of progesterone complexed with its receptor.
    Williams SP; Sigler PB
    Nature; 1998 May; 393(6683):392-6. PubMed ID: 9620806
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Transition from monomeric to homodimeric DNA binding by nuclear receptors: identification of RevErbAalpha determinants required for RORalpha homodimer complex formation.
    Moraitis AN; Giguère V
    Mol Endocrinol; 1999 Mar; 13(3):431-9. PubMed ID: 10077000
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Structural basis of RXR-DNA interactions.
    Zhao Q; Chasse SA; Devarakonda S; Sierk ML; Ahvazi B; Rastinejad F
    J Mol Biol; 2000 Feb; 296(2):509-20. PubMed ID: 10669605
    [TBL] [Abstract][Full Text] [Related]  

  • 39. NMR investigation of main-chain dynamics of the H80E mutant of bovine neurophysin-I: demonstration of dimerization-induced changes at the hormone-binding site.
    Naik MT; Lee H; Bracken C; Breslow E
    Biochemistry; 2005 Sep; 44(35):11766-76. PubMed ID: 16128578
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Structural and evolutionary analysis of the co-activator binding domain in vertebrate progesterone receptors.
    Kattoula SR; Baker ME
    J Steroid Biochem Mol Biol; 2014 May; 141():7-15. PubMed ID: 24388949
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.